# Corcept targets $3B-$5B in Cushing’s revenue in 2030 as it awaits December 17 relacorilant FDA decision

- Source: Seeking Alpha Market Currents
- Published: 2026-11-04T00:47:26+00:00
- Category: Markets
- Original: https://seekingalpha.com/news/4664362-corcept-targets-3b-5b-in-cushing-s-revenue-in-2030-as-it-awaits-december-17-relacorilant-fda?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
- Canonical: https://groundlevelnews.com/story/corcept-targets-3b-5b-in-cushing-s-revenue-in-2030-as-it-awaits-decemb-814e13/

Read the full report from the original publisher.

_Ground Level News shows a short summary only; the full article and all rights belong to Seeking Alpha Market Currents._